Catalyst Pharmaceuticals Inc
(14888U101)
Funds Reporting Holdings of Catalyst Pharmaceuticals Inc according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Consonance Capital Management LP | 17,875,655 | $68,643k | Jun 30, 2019 | Aug 14, 2019 | |
Armistice Capital LLC | 5,000,000 | $19,200k | Jun 30, 2019 | Aug 14, 2019 | |
Mangrove Partners | 3,837,181 | $14,735k | Jun 30, 2019 | Aug 14, 2019 | |
Broadfin Capital LLC | 2,765,070 | $10,618k | Jun 30, 2019 | Aug 14, 2019 | |
Baker BROS Advisors LP | 2,559,461 | $9,828k | Jun 30, 2019 | Aug 14, 2019 | |
Gables Capital Management Inc | 486,064 | $1,869k | Jun 30, 2019 | Jul 31, 2019 | |
Brandywine Global Investment Management LLC | 349,072 | $1,341k | Jun 30, 2019 | Aug 14, 2019 | |
Panagora Asset Management Inc | 297,238 | $1,141k | Jun 30, 2019 | Aug 9, 2019 | |
Acadian Asset Management LLC | 76,416 | $293k | Jun 30, 2019 | Aug 8, 2019 | |
Prelude Capital Management LLC | 23,270 | $89k | Jun 30, 2019 | Aug 14, 2019 | |
Provise Management Group LLC | 19,000 | $73k | Jun 30, 2019 | Aug 9, 2019 | |
QS Investors LLC | 1,182 | $5k | Jun 30, 2019 | Aug 14, 2019 |